Mari A. Bernabeu-MartõÂnez, Mateo Ramos Merino, Juan M. Santos Gago, Luis
M.AÂ lvarez Sabucedo, Carmina Wanden-Berghe, Javier Sanz-Valero
Objective: To review the scientific literature related to the safe handling of hazardous drugs (HDs).
Method: Critical analysis of works retrieved from MEDLINE, the Cochrane Library, Scopus, CINHAL, Web of Science and LILACS using the terms “Hazardous Substances”, “Antineoplastic Agents” and “Cytostatic Agents”, applying “Humans” and “Guidelines” as filters. Date of search: January 2017.
Results: In total, 1100 references were retrieved, and from those, 61 documents were selected based on the inclusion and exclusion criteria: 24 (39.3%) documents related to recommendations about HDs; 27 (44.3%) about antineoplastic agents, and 10 (33.3%) about other types of substances (monoclonal antibodies, gene medicine and other chemical and biological agents). In 14 (23.3%) guides, all the stages in the manipulation process involving a risk due to exposure were considered. Only one guide addressed all stages of the handling process of HDs (including stages with and without the risk of exposure).
The most described stages were drug preparation (41 guides, 67.2%), staff training and/or patient education (38 guides, 62.3%), and administration (37 guides, 60.7%). No standardized informatics system was found that ensured quality management, traceability and minimization of the risks associated with these drugs.
Conclusions: Most of the analysed guidelines limit their recommendations to the manipulation of antineoplastics. The most frequently described activities were preparation, training, and administration.
It would be convenient to apply ICTs (Information and Communications Technologies) to manage processes involving HDs in a more complete and simpler fashion.
Read the full study here.
If you liked this study, you might also like: